RECOGNIFY LIFE SCIENCES
Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").
More informations about "Recognify Life Sciences"
Recognify Life Sciences - Crunchbase Company Profile & Funding
Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").See details»
Atai and Recognify's schizophrenia drug fails to meet main goal in ...
Jul 25, 2025 Atai Life Sciences and its partner Recognify Life Sciences said on Friday their experimental drug did not meet the main goal in a mid-stage trial for patients with …See details»
Organization | Recognify Life Sciences
Recognify Life Sciences Report issue For profit Phase 2 Founded: New YOrk NY United States (2013) Organization Overview First Clinical Trial 2021 NCT04822883 First Marketed Drug …See details»
Recognify Life Sciences 2025 Company Profile: …
Nov 2, 2020 Information on acquisition, funding, cap tables, investors, and executives for Recognify Life Sciences. Use the PitchBook Platform to explore the full profile.See details»
Recognify Life Sciences - 2025 Company Profile & Team - Tracxn
May 24, 2025 Recognify Life Sciences - Developing treatments for cognitive impairment associated with schizophrenia. Founded by Gary Walker and Matt Pando in the year 2018. …See details»
Recognify Life Sciences, Inc. - Drug pipelines, Patents, Clinical ...
Explore Recognify Life Sciences, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 5 news, Technology Platform:Small molecule ...See details»
Pipeline - atai Life Sciences
1. Majority ownership stake in Recognify Life Sciences VLS-01 is a proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine (DMT) applied to the buccal surface, being developed for the treatment of people suffering from …See details»
Team — Recognify Life Sciences
Dr. Walker is a biomedical engineer and neuroscientist leading the clinical development for Recognify with over 20 years of professional experience in the development and …See details»
Recognify Life Sciences - Catalio Capital Portfolio
Recognify Life Sciences is a clinical stage company developing a novel small molecule for the treatment of Alzheimer’s Disease. Recognify Life Sciences is a clinical stage pharmaceutical …See details»
Recognify Life Sciences - BIO International Convention 2025
Recognify Life Sciences is a clinical stage therapeutics company focused on impacting the quality of life of patients with central nervous system diseases and disorders through the …See details»
atai Life Sciences Acquires Majority Stake in Recognify Life …
NEW YORK, Jan. 12, 2021 /PRNewswire/ -- atai Life Sciences (" atai" or the " Company"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health …See details»
Recognify Life Sciences - News & Analysis - Crunchbase
Jul 28, 2025 Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").See details»
Blog 3 — Recognify Life Sciences
An atai Life Sciences hosted event featuring a presentation by Key Opinion Leader (KOL) Richard S.E. Keefe, PhD, of Duke University. Dr. Keefe discussed the current treatment landscape and …See details»
Recognify Life Sciences - Drug pipelines, Patents, Clinical trials ...
About Recognify Life Sciences, Inc. Recognify Life Sciences is a biotech company leveraging a Phase 2 ready asset to treat Cognitive Impairment Associated with Schizophrenia (CIAS). …See details»
Recognify Life Sciences Provides Update on Phase 2b Trial of ...
Jul 25, 2025 About Recognify Life Sciences, Inc. Recognify Life Sciences is a clinical-stage biotech company on a mission to provide pro-cognitive treatments solutions to mental health …See details»
Recognify Life Sciences Provides Update on Phase 2b Trial of ...
SOUTH SAN FRANCISCO, July 25, 2025 (GLOBE NEWSWIRE) -- Recognify Life Sciences, a clinical-stage biotech company focused on developing treatments for cognitive impairment, …See details»
Contact 1 — Recognify Life Sciences
Last Name Email * Message * Thank you! Recognify Life Sciences, Inc Our Work News TeamSee details»
atai Life Sciences Reports Second Quarter 2025 Financial Results …
1 day ago Recognify Life Sciences plans to analyze the full data set and evaluate strategic options for inidascamine based on the totality of data. As previously communicated, atai …See details»
atai Life Sciences Reports Second Quarter 2025 Financial
4 hours ago Recognify Life Sciences plans to analyze the full data set and evaluate strategic options for inidascamine based on the totality of data. As previously communicated, atai …See details»
ATAI Life Sciences acquires Recognify Life Sciences - 2021-01-12 ...
Overview Acquired Organization: Recognify Life Sciences Recognify Life Sciences is an entity developing a treatment for Cognitive Impairment associated with Schizophrenia ("CIAS").See details»